Becton Dickinson price target raised to $279 from $278 at Barclays
Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...
Zacks.com on MSN2d
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit
Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...
Becton Dickinson to Split from Bioscience and Diagnostic Solutions Arms
American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...
Morningstar1d
Becton Dickinson & Co BDX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Can Sustained Product Demand Drive BDX Stock Before Q1 Earnings?
The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...
MassDevice8d
BD announces intent to sell Life Sciences business, beats Street in Q1
BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for.
Morningstar2d
Becton Dickinson & Co BDX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...